Abstract

Claudia Fischbach-Teschl is the Stanley Bryer 1946 Professor of Biomedical Engineering at Cornell University, Director of Cornell’s Physical Sciences Oncology Center (PSOC) on the Physics of Cancer Metabolism, and Associate Director of Cornell Nanoscale Science and Engineering Facility (CNF). She received her Ph.D. in Pharmaceutical Technology from the University of Regensburg, Germany and conducted her postdoctoral work at Harvard University in the Division of Engineering and Applied Sciences. She became a faculty member at Cornell in 2007 where she utilizes engineering tools and strategies to gain a better understanding of how tumor-microenvironment interactions regulate cancer development, progression, and therapy resistance with a focus on cell-ECM interactions. She is a fellow of the American Institute for Medical and Biological Engineering (AIMBE), the Biomedical Engineering Society, and the Alexander von Humboldt Foundation in Germany. She served on the Tumor Microenvironment study section, is a Senior Editor of Cancer Research and serves on the Editorial Board of the ACS journal Biomaterials Science and Engineering and Tissue Engineering. She is an advocate for interdisciplinary cancer research (e.g. as Chair of the 2019 Gordon Conference on the ‘Physical Science of Cancer’) and has written Op-Ed articles on this topic including in Scientific American.